Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in CDNA — CareDx, Inc.

CIK 1423053 MIAMI, FL
Back to CDNA Full portfolio

Position in CDNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,049,044
+$1,587,802 QoQ
Shares Held
106,984
+27.1% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 225 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDNA Over Time

Shares Held

Position Value (USD)

Derivatives in CDNA

reported options exposure · as of Jun 30, 2026
CallValue
$401,850
CallShares
14,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,783,709,630 across 35 Diagnostics & Research names. CDNA ranks #22 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 574,992 $288,277,988
2 CRL
Charles River Laboratories International, Inc.
 1,193,601 $270,696,770
3 GH
Guardant Health, Inc.
 1,449,534 $217,473,585
4 DHR
Danaher Corp /De/
 943,694 $179,754,833
5 RVTY
Revvity, Inc.
 1,457,335 $162,143,091
6 A
Agilent Technologies, Inc.
 1,101,501 $146,312,377
7 TWST
Twist Bioscience Corp
 862,042 $88,686,880
8 NTRA
Natera, Inc.
 265,607 $72,099,020

All Filings in CDNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,049,044 106,984
2026-06-30 $401,850 14,100
2026-03-31 $1,461,242 84,173
2025-12-31 $12,109,635 642,762
2025-12-31 $538,824 28,600
2025-09-30 $600,502 41,300
2025-09-30 $9,070,240 623,813
2025-09-30 $173,026 11,900
2025-06-30 $621,372 31,800
2025-06-30 $15,449,632 790,667
2025-03-31 $88,750 5,000
2025-03-31 $280,450 15,800
2025-03-31 $14,090,162 793,812
2024-12-31 $10,920,042 510,044
2024-12-31 $124,178 5,800
2024-12-31 $421,777 19,700
2024-09-30 $796,237 25,500
2024-09-30 $12,854,926 411,687
2024-09-30 $309,127 9,900
2024-06-30 $372,720 24,000
2024-06-30 $155,300 10,000
2024-06-30 $1,871,380 120,501
2024-03-31 $83,661 7,900
2024-03-31 $104,841 9,900
2024-03-31 $847,845 80,061
2023-12-31 $1,883,352 156,946
2023-12-31 $78,000 6,500
2023-12-31 $30,000 2,500
2023-09-30 $1,356,075 193,725
2023-09-30 $36,400 5,200
2023-09-30 $56,700 8,100
2023-06-30 $96,050 11,300
2023-06-30 $1,012,664 119,137
2023-06-30 $119,000 14,000
2023-03-31 $3,910,694 427,866
2023-03-31 $81,346 8,900
2023-03-31 $144,412 15,800
2022-12-31 $320,621 28,100
2022-12-31 $37,653 3,300
2022-12-31 $2,570,352 225,272
2022-09-30 $369,334 21,700
2022-09-30 $7,690,673 451,861
2022-06-30 $496,188 23,100
2022-06-30 $287,832 13,400
2022-06-30 $5,195,624 241,882
2022-03-31 $495,666 13,400
2022-03-31 $591,840 16,000
2022-03-31 $7,152,681 193,368
2021-12-31 $1,405,332 30,900
2021-12-31 $2,078,436 45,700

Report a Problem

Category
Description
Email (optional, for follow-up)